Does TOFACITINIB Cause Prostate cancer? 125 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 125 reports of Prostate cancer have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
125
Reports of Prostate cancer with TOFACITINIB
0.1%
of all TOFACITINIB reports
3
Deaths
27
Hospitalizations
How Dangerous Is Prostate cancer From TOFACITINIB?
Of the 125 reports, 3 (2.4%) resulted in death, 27 (21.6%) required hospitalization, and 9 (7.2%) were considered life-threatening.
Is Prostate cancer Listed in the Official Label?
Yes, Prostate cancer is listed as a known adverse reaction in the official FDA drug label for TOFACITINIB.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Prostate cancer?
RANITIDINE (60,641)
LEUPROLIDE (1,736)
ABIRATERONE (661)
ENZALUTAMIDE (642)
ADALIMUMAB (573)
ETANERCEPT (482)
METHOTREXATE (444)
INFLIXIMAB (376)
LENALIDOMIDE (366)
PREDNISONE (317)
Which TOFACITINIB Alternatives Have Lower Prostate cancer Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN